Louise Linde

5PUBLICATIONS

22CO-AUTHORS

Toxicology (incl. clinical toxicology)Other European languagesCancer therapy (excl. chemotherapy and radiation therapy)Pharmacogenomics

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jun 26, 2024

Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries.

Louise Linde, Stylianos Georgiadis, Lykke M Ørnbjerg

|Oct 20, 2023

Commonalities and differences in set-up and data collection across European spondyloarthritis registries - results from the EuroSpA collaboration.

Louise Linde, Lykke M Ørnbjerg, Simon H Rasmussen

|Sep 22, 2023

Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switching.

Louise Linde, Lykke Midtbøll Ørnbjerg, Cecilie Heegaard Brahe

|Jun 14, 2023

Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries.

Louise Linde, Lykke M Ørnbjerg, Stylianos Georgiadis

Pageof 1

Frequent Collaborators

3 joint publications

Johan Karlsson Wallman

2 joint publications

Lykke Midtbøll Ørnbjerg

2 joint publications

Daniela Di Giuseppe

2 joint publications

Isabel Castrejon

2 joint publications

Florenzo Iannone

2 joint publications

Gary J Macfarlane

2 joint publications

Burkhard Möller

2 joint publications

Maria José Santos

2 joint publications

Merete Lund Hetland

2 joint publications

Mikkel Østergaard

Frequent Collaborators

3 joint publications

Johan Karlsson Wallman

2 joint publications

Lykke Midtbøll Ørnbjerg

2 joint publications

Daniela Di Giuseppe

2 joint publications

Isabel Castrejon